Received Feb 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
shingles on eye; shingles on my face and nose; This serious case was reported by a consumer via interactive digital media and described the occurrence of ophthalmic herpes zoster in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, 6 days after receiving Shingles vaccine, the patient experienced ophthalmic herpes zoster (Verbatim: shingles on eye) (serious criteria GSK medically significant) and facial herpes zoster (Verbatim: shingles on my face and nose). The outcome of the ophthalmic herpes zoster and facial herpes zoster were resolved (duration 8 weeks). It was unknown if the reporter considered the ophthalmic herpes zoster and facial herpes zoster to be related to Shingles vaccine. The company considered the ophthalmic herpes zoster to be unrelated to Shingles vaccine. It was unknown if the company considered the facial herpes zoster to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 19-JAN-2025 The case was received from the patient via interactive digital media. The patient got the shingle shot and about 6 days later, had shingles on his/her face, eye and nose. The patient got medications and it clear up again in his/her face and other spots . The patient reported that finally after 8 weeks, things cleared up. The patient did not get the second dose of the shot.; Sender's Comments: Ophthalmic herpes zoster is an unlisted event which is considered unrelated to GSK vaccine Shingles vaccine.